Cargando…

The Evolving Epidemiology of Amyloidosis

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Wechalekar, Ashutosh D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543143/ https://www.ncbi.nlm.nih.gov/pubmed/34729525 http://dx.doi.org/10.1016/j.jaccao.2021.09.001

Ejemplares similares

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

Systemic Amyloidosis in England: an epidemiological study
por: Pinney, Jennifer H, et al.
Publicado: (2013)

Updates in Cardiac Amyloidosis: A Review
por: Banypersad, Sanjay M., et al.
Publicado: (2012)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
por: Wechalekar, Ashutosh D., et al.
Publicado: (2022)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds
por: Wagner, T., et al.
Publicado: (2018)

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
por: Wechalekar, A D, et al.
Publicado: (2017)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
por: Pinney, Jennifer H., et al.
Publicado: (2013)

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis
por: Rezk, Tamer, et al.
Publicado: (2019)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Study on epidemiology of cutaneous amyloidosis in northern India and effectiveness of dimethylsulphoxide in cutaneous amyloidosis
por: Krishna, Arvind, et al.
Publicado: (2012)

Cardiac amyloidosis: evolving pathogenesis, multimodal diagnostics, and principles of treatment
por: Medarametla, Gnana Deepthi, et al.
Publicado: (2023)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
por: Gilbertson, JA, et al.
Publicado: (2015)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

Deferred autologous stem cell transplantation in systemic AL amyloidosis
por: Manwani, Richa, et al.
Publicado: (2018)

Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies
por: Porcari, Aldostefano, et al.
Publicado: (2022)

The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis
por: Banypersad, Sanjay M
Publicado: (2019)

Amyloidosis: What does pathology offer? The evolving field of tissue biopsy
por: Riefolo, Mattia, et al.
Publicado: (2022)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2017)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021)

Re-Definition of the Epidemiology of Cardiac Amyloidosis
por: Rossi, Maddalena, et al.
Publicado: (2022)

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation
por: Agis, Hermine
Publicado: (2017)

P910: DISPARATE PREDICTION OF OUTCOMES IN A UNIFORMLY TREATED COHORT OF PATIENTS WITH AL AMYLOIDOSIS STRATIFIED BY MAYO 2012 AND EUROPEAN CARDIAC STAGING SYSTEMS
por: Khwaja, Jahanzaib, et al.
Publicado: (2023)

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
por: Sharpley, Faye A., et al.
Publicado: (2019)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
por: Saez, Maria S., et al.
Publicado: (2021)

The evolving epidemiology of stone disease
por: Roudakova, Ksenia, et al.
Publicado: (2014)

An evolving common language in epidemiology
por: Lahariya, Chandrakant
Publicado: (2015)

The evolving epidemiology of monkeypox virus
por: Li, Heng, et al.
Publicado: (2022)

Systemic AA amyloidosis: epidemiology, diagnosis, and management
por: Real de Asúa, Diego, et al.
Publicado: (2014)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis
por: Cohen, Oliver C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5deil85d00v1ado7rlgjfumhar